Vitamin D Deficiency: Symptoms, Testing, and What to Do

Vitamin D deficiency is the most prevalent nutritional deficiency in the United States, affecting an estimated 40 percent of adults by most clinical definitions and a higher percentage when functional optimal targets are used rather than the conservative deficiency thresholds. Despite this prevalence, deficiency remains underdiagnosed because its symptoms are nonspecific, the test is often omitted from standard panels, and the medical community has historically underestimated how consequential insufficiency is at levels short of frank deficiency. This guide covers what vitamin D actually does in the body, how to recognize deficiency, what target levels to aim for, and how correction protocols are structured to restore status without overshooting.

Vitamin D Deficiency: What Vitamin D Actually Does

Vitamin D is not a conventional vitamin in the traditional sense. It functions as a steroid hormone, binding to vitamin D receptors (VDR) found in virtually every tissue in the body. The historic framing as a “bone vitamin” reflects what was easiest to study early on, not the breadth of its actual physiological roles. Once the VDR was identified in tissues throughout the body, the picture broadened substantially. The NIH Office of Dietary Supplements monograph on vitamin D outlines the consensus on its role across multiple body systems and the population-level prevalence of insufficiency.

The downstream effects extend far beyond calcium absorption and bone health, and patients who are insufficient often present with symptoms that span multiple systems rather than the single bone-pain pattern that older clinical training emphasized.

Immune regulation. VDR activation modulates both innate and adaptive immune responses. Deficiency is associated with increased susceptibility to viral and bacterial infection, autoimmune conditions, and impaired immune surveillance. The role of vitamin D in respiratory infection, in particular, has been heavily studied, with a BMJ meta-analysis on vitamin D supplementation and acute respiratory infection showing benefit in deficient individuals.

Hormone production. VDR receptors are present in Leydig cells (testosterone production) and ovarian follicle cells. Vitamin D deficiency is associated with lower testosterone in men and hormonal dysregulation in women with PCOS. For patients pursuing TRT or HRT evaluation, vitamin D status is a relevant baseline marker because correcting it sometimes shifts the picture meaningfully before other interventions are needed.

Insulin sensitivity. Vitamin D modulates pancreatic beta-cell function and peripheral insulin sensitivity. Deficiency is associated with higher rates of insulin resistance and type 2 diabetes. Patients on weight loss programs benefit from vitamin D status optimization both for the metabolic effect and for the energy and mood benefits that compound with improved metabolic flexibility.

Mood and cognition. VDR receptors are present throughout the brain, particularly in areas regulating mood, memory, and cognition. Deficiency is strongly associated with depression, seasonal mood decline, and cognitive complaints. The seasonal pattern of mood changes that affects many adults in higher latitudes correlates with vitamin D status and often improves with correction of insufficiency.

Muscle function. Vitamin D is required for optimal muscle protein synthesis and neuromuscular function. Deficiency is a common and underrecognized cause of muscle weakness, generalized myalgia, and the diffuse aching that patients sometimes describe as “feeling old before their time.”

Cardiovascular health. VDR activation modulates blood pressure regulation, cardiac muscle function, and inflammatory pathways. Low vitamin D is consistently associated with higher cardiovascular risk in observational studies, though the intervention trial evidence on whether supplementation reverses this risk is less definitive than the association data.

Symptoms That May Indicate Vitamin D Deficiency

The symptom picture of vitamin D deficiency overlaps heavily with general nonspecific complaints, which is why deficiency goes undiagnosed for years in many patients. The pattern that should raise suspicion includes fatigue and low energy not explained by sleep quality, bone pain or generalized musculoskeletal aching (particularly in the lower back, hips, and legs), and muscle weakness with specific difficulty managing stairs or rising from chairs.

Patients also often describe frequent illness or slow recovery from infections, low mood (including seasonal mood decline), hair thinning, and slow wound healing. None of these is specific to vitamin D deficiency in isolation, but the combination, particularly when several appear together and standard workups have been negative, should prompt testing 25-hydroxyvitamin D as part of the evaluation.

Target Levels: Why the Standard Reference Range Falls Short

The conventional reference range for 25-hydroxyvitamin D identifies deficiency below 20 ng/mL and insufficiency below 30 ng/mL. These thresholds were originally calibrated for bone health outcomes alone, specifically for the prevention of rickets and severe osteomalacia. They were not calibrated for immune function, hormone production, mood regulation, or metabolic health, all of which appear to require higher levels for optimal function.

Emerging evidence from observational and interventional studies suggests optimal function across these systems requires levels of 40 to 60 ng/mL or higher. Many patients with levels of 25 to 35 ng/mL are technically “sufficient” by the standard reference range but functionally suboptimal for immune, hormonal, and metabolic function. The clinical target most useful for adults pursuing comprehensive optimization is 50 to 70 ng/mL. This range is above the conventional threshold but well below the level associated with toxicity risk (typically above 100 to 150 ng/mL with prolonged exposure).

Correction Protocol: Dose, Form, and Duration

Vitamin D3 (cholecalciferol) is the preferred supplemental form. It is substantially more effective than D2 (ergocalciferol) for raising serum levels, has a longer half-life, and is the form the body itself produces in skin under UVB exposure. D3 is what most over-the-counter supplements contain, but it is worth checking labels because some prescription products and some less expensive supplements still use D2.

Dosing is guided by baseline level, body weight, and absorption capacity. A reasonable framework distinguishes three protocols based on where the patient is starting from. For severe deficiency below 20 ng/mL, the initial protocol typically uses 50,000 IU vitamin D3 weekly for 8 to 12 weeks, then transitions to maintenance dosing once levels are restored. For insufficiency in the 20 to 40 ng/mL range, daily dosing of 4,000 to 6,000 IU for 12 to 16 weeks before retesting is the more typical approach. For maintenance once the target range is reached, 2,000 to 4,000 IU daily generally maintains status, with the exact dose depending on sun exposure, dietary intake, body weight, and absorption.

Vitamin D3 should always be taken with vitamin K2 (MK-7 form) when using high doses. The reasoning is that vitamin D increases calcium absorption from the gut, and K2 directs that calcium toward bone deposition rather than soft tissue (vascular and arterial) calcification. Without adequate K2, high-dose vitamin D supplementation theoretically increases the risk of arterial calcification by raising calcium availability without ensuring it reaches the right destinations. The MK-7 form of K2 has the longest half-life and the strongest evidence base. Vitamin D is fat-soluble and absorbed best when taken with the largest meal of the day rather than on an empty stomach.

Retesting and Maintenance

The retest at 12 weeks after starting a correction protocol is the most important single step in the workflow. Absorption varies significantly between individuals based on genetics, gut function, body weight, and vitamin D-binding protein status. Lab confirmation prevents both persistent deficiency (where the patient is still under-treated despite supplementation) and unintended over-supplementation (where the patient has reached the target range and continued high doses risk pushing into the upper part of the safe range unnecessarily).

Once the target range is reached, annual or biannual retesting during the late winter months (when levels are typically at their lowest) is sufficient for most patients. Patients with malabsorption issues, post-bariatric surgery patients, and patients on certain medications that affect vitamin D metabolism may need more frequent monitoring. The point of monitoring is not to chase a number but to confirm that the maintenance protocol is producing the intended status.

Common Patient Questions

Can I get enough vitamin D from sun exposure? Theoretically yes, in summer months, in lower latitudes, with adequate skin exposure during midday hours. Practically no for most people who live north of about 35 degrees latitude (roughly the line from Atlanta to Los Angeles), who work indoors, or who use sunscreen consistently. The recommendation to “just get more sun” oversimplifies what most adults can realistically achieve and ignores the skin cancer risk of unprotected sun exposure long enough to produce adequate vitamin D synthesis.

Are there foods that have enough vitamin D to maintain levels? Few. Fatty fish (salmon, mackerel, sardines) and egg yolks contain meaningful amounts. Most fortified foods contribute modest quantities. Diet alone rarely maintains optimal levels in adults who are not eating fatty fish multiple times per week, which is why supplementation is the practical maintenance strategy for most patients.

Can I take too much vitamin D? Yes, but it requires sustained high doses. Toxicity is unusual at maintenance doses below 4,000 IU daily. Doses above 10,000 IU daily for prolonged periods can produce hypercalcemia (elevated blood calcium), which causes nausea, fatigue, kidney issues, and in severe cases vascular calcification. The retest at 12 weeks is what prevents inadvertent over-supplementation in patients who absorb particularly well.

Why is K2 important? K2 directs calcium to bone rather than soft tissue. With high-dose vitamin D, more calcium is absorbed from the gut. Without K2, that calcium can deposit in arteries and other soft tissues. With K2, it preferentially deposits in bone and teeth. The MK-7 form is the preferred K2 form due to its longer half-life and strongest evidence base.

How does vitamin D interact with my other supplements or medications? The major interactions are with thiazide diuretics (which can raise calcium when combined with vitamin D), corticosteroids (which can lower vitamin D effect), and some seizure medications (which accelerate vitamin D metabolism, requiring higher doses). Patients on these medications need provider review of supplementation plans rather than self-adjusting.

The Bottom Line

Vitamin D deficiency is common, often missed, and capable of contributing to a remarkably broad range of symptoms because of how widely VDR is distributed across body tissues. The conventional reference range understates what optimal looks like, and a value labeled “sufficient” by population standards may still be functionally inadequate for the patient’s symptoms and goals. The correction protocol is straightforward when guided by baseline lab values, weight, and follow-up testing. D3 with K2 (MK-7) taken with a meal, dosed to baseline, with a retest at 12 weeks, restores most patients to optimal range. The harder problem is the diagnostic step (recognizing that vitamin D status might be part of what’s going on) which is why testing it as part of a comprehensive workup matters more than guessing at supplementation does.

Medically Reviewed By

Dr. Ashar N., DNP, APRN, FNP-C, PMHNP-BC

Co-Founder & Medical Director at Tactus Health. Dual board-certified, with clinical focus on wellness, hormone optimization, and medical weight loss. Sugar Hill, GA and telehealth for Georgia patients.